These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 19641496

  • 1. The role of HRK gene in human cancer.
    Nakamura M, Shimada K, Konishi N.
    Oncogene; 2008 Dec; 27 Suppl 1():S105-13. PubMed ID: 19641496
    [Abstract] [Full Text] [Related]

  • 2. HRK inactivation associated with promoter methylation and LOH in prostate cancer.
    Higuchi T, Nakamura M, Shimada K, Ishida E, Hirao K, Konishi N.
    Prostate; 2008 Jan 01; 68(1):105-13. PubMed ID: 18008329
    [Abstract] [Full Text] [Related]

  • 3. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.
    Nakamura M, Ishida E, Shimada K, Nakase H, Sakaki T, Konishi N.
    Acta Neuropathol; 2005 Oct 01; 110(4):402-10. PubMed ID: 16155764
    [Abstract] [Full Text] [Related]

  • 4. Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas.
    Nakamura M, Ishida E, Shimada K, Nakase H, Sakaki T, Konishi N.
    Oncology; 2006 Oct 01; 70(3):212-21. PubMed ID: 16809940
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R, Setien F, Espada J, Artiga MJ, Rodriguez M, Pérez-Rosado A, Sanchez-Aguilera A, Fraga MF, Piris MA, Esteller M.
    J Clin Oncol; 2005 Jun 10; 23(17):3940-7. PubMed ID: 15867203
    [Abstract] [Full Text] [Related]

  • 6. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
    Xu M, Chen X, Chen N, Nie L, Li X, Li Q, Zeng H, Zhou Q.
    Am J Pathol; 2013 Jan 10; 182(1):84-95. PubMed ID: 23159945
    [Abstract] [Full Text] [Related]

  • 7. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
    Vetterkind S, Boosen M, Scheidtmann KH, Preuss U.
    Int J Oncol; 2005 Jan 10; 26(1):159-67. PubMed ID: 15586236
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic mechanisms of tumorigenesis.
    Farrell WE.
    Horm Metab Res; 2005 Jun 10; 37(6):361-8. PubMed ID: 16001328
    [Abstract] [Full Text] [Related]

  • 9. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
    Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, Li H, Shu XS, Li H, Liu W, Luo B, Zhang Q, Mok TS, Zheng W, Qiu X, Srivastava G, Yu J, Sung JJ, Chan AT, Ma D, Tao Q, Han W.
    Cancer Res; 2009 Jun 15; 69(12):5194-201. PubMed ID: 19509237
    [Abstract] [Full Text] [Related]

  • 10. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
    Courts C, Brunn A, Montesinos-Rongen M, Siemer D, Hans V, Paulus W, Wiestler OD, Küppers R, Siebert R, Deckert M.
    J Neuropathol Exp Neurol; 2009 Sep 15; 68(9):972-6. PubMed ID: 19680146
    [Abstract] [Full Text] [Related]

  • 11. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ.
    Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956
    [Abstract] [Full Text] [Related]

  • 12. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
    Ivascu C, Wasserkort R, Lesche R, Dong J, Stein H, Thiel A, Eckhardt F.
    Int J Biochem Cell Biol; 2007 Aug 15; 39(7-8):1523-38. PubMed ID: 17433759
    [Abstract] [Full Text] [Related]

  • 13. Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
    Courts C, Montesinos-Rongen M, Brunn A, Bug S, Siemer D, Hans V, Blümcke I, Klapper W, Schaller C, Wiestler OD, Küppers R, Siebert R, Deckert M.
    J Neuropathol Exp Neurol; 2008 Jul 15; 67(7):720-7. PubMed ID: 18596541
    [Abstract] [Full Text] [Related]

  • 14. Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.
    Chang I, Majid S, Saini S, Zaman MS, Yamamura S, Chiyomaru T, Shahryari V, Fukuhara S, Deng G, Dahiya R, Tanaka Y.
    Mol Cancer Ther; 2013 Jun 15; 12(6):1049-59. PubMed ID: 23580416
    [Abstract] [Full Text] [Related]

  • 15. Methylated genes as new cancer biomarkers.
    Duffy MJ, Napieralski R, Martens JW, Span PN, Spyratos F, Sweep FC, Brunner N, Foekens JA, Schmitt M, EORTC PathoBiology Group.
    Eur J Cancer; 2009 Feb 15; 45(3):335-46. PubMed ID: 19138839
    [Abstract] [Full Text] [Related]

  • 16. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
    Booman M, Szuhai K, Rosenwald A, Hartmann E, Kluin-Nelemans H, de Jong D, Schuuring E, Kluin P.
    J Pathol; 2008 Oct 15; 216(2):209-17. PubMed ID: 18729069
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
    Taniguchi H, Fernández AF, Setién F, Ropero S, Ballestar E, Villanueva A, Yamamoto H, Imai K, Shinomura Y, Esteller M.
    Cancer Res; 2009 Nov 01; 69(21):8447-54. PubMed ID: 19861541
    [Abstract] [Full Text] [Related]

  • 18. A novel apoptosis gene identified in the pituitary gland.
    Farrell WE.
    Neuroendocrinology; 2006 Nov 01; 84(4):217-21. PubMed ID: 17135715
    [Abstract] [Full Text] [Related]

  • 19. The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer.
    Murphy TM, Perry AS, Lawler M.
    Endocr Relat Cancer; 2008 Mar 01; 15(1):11-25. PubMed ID: 18310272
    [Abstract] [Full Text] [Related]

  • 20. Inflammation-related aberrant patterns of DNA methylation: detection and role in epigenetic deregulation of cancer cell transcriptome.
    Suzuki H, Toyota M, Kondo Y, Shinomura Y.
    Methods Mol Biol; 2009 Mar 01; 512():55-69. PubMed ID: 19347273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.